Clinical Trial Update: Oncometabolome and MALDI-MSI in Upper GI Carcinomas - Chemosensitivity in Esophageal Carcinoma

View source ↗

Summary

This clinical trial registry entry describes an exploratory study using oncometabolomics and MALDI-MSI to assess chemosensitivity in upper GI cancers. It focuse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Esophageal Cancer

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Esophagus Adenocarcinoma, Esophagus Cancer | Status: ACTIVE_NOT_RECRUITING